(64 days)
Implantation of a port and catheter is indicated whenever patient therapy requires repeated intravascular injection or continuous infusion of fluids, medications, antibiotics, nutritionals and the withdrawal of venous blood samples.
The port kit provides an implantable port and polyurethane catheter, an introducer sheath/dilator, a 22 Ga. non-coring needle, a 21 Ga. entry needle, a 20 Ga. blunt needle, and 0.018" guidewire.
I am sorry, but based on the provided text, there is no information about acceptance criteria, device performance, or any study conducted to prove the device meets specific criteria. The document is a 510(k) summary and an FDA letter, which primarily discusses the substantial equivalence of the Vaxcel Implantable Vascular Access System to predicate devices and regulatory compliance.
Therefore, I cannot populate the table or answer the specific questions about studies and data.
§ 880.5965 Subcutaneous, implanted, intravascular infusion port and catheter.
(a)
Identification. A subcutaneous, implanted, intravascular infusion port and catheter is a device that consists of a subcutaneous, implanted reservoir that connects to a long-term intravascular catheter. The device allows for repeated access to the vascular system for the infusion of fluids and medications and the sampling of blood. The device consists of a portal body with a resealable septum and outlet made of metal, plastic, or combination of these materials and a long-term intravascular catheter is either preattached to the port or attached to the port at the time of device placement. The device is available in various profiles and sizes and can be of a single or multiple lumen design.(b)
Classification. Class II (special controls) Guidance Document: “Guidance on 510(k) Submissions for Implanted Infusion Ports,” FDA October 1990.